Raj Manda
Keine laufenden Positionen mehr
Profil
Raj Manda worked as a Senior Analyst at Human Genome Sciences, Inc. and as a Consulting Science Advisor at Synogen Development Group LLC.
Prior to that, he had no titles at the University of Florida.
Dr. Manda holds an MBA and a doctorate from the University of Florida.
Ehemalige bekannte Positionen von Raj Manda
| Unternehmen | Position | Ende |
|---|---|---|
Synogen Development Group LLC
 Synogen Development Group LLC Investment ManagersFinance Synogen Inc (Synogen) is a venture capital firm founded in 2003 by Jamie M. Grooms and Richard R. Allen. The firm is headquartered in Gainesville, Florida. | Corporate Officer/Principal | 01.09.2008 |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | - |
| University of Florida | Finanzdirektor/CFO | 18.08.2011 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Synogen Development Group LLC
Synogen Development Group LLC Investment ManagersFinance Synogen Inc (Synogen) is a venture capital firm founded in 2003 by Jamie M. Grooms and Richard R. Allen. The firm is headquartered in Gainesville, Florida. | Finance |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
